Obviously the fight took steam out from movie goers. If it wasn't for the fight this weekend, Avengers would have surely hit over $200 million at the box office. What bad timing!!!
that was in reference to your question! they also talked about giving holland 500 old trailers and having them reboxed!
The mention of Auto industry business also helped fuel the spike. CY will be another TXN with the acquisition of Spans. Look like the MM's took out a lot of stops during Friday, now the price will gradually creep upwards. NXPI is another example.
I ask myself...what if I had a family member with a cancer that could be helped by ANY of the Advaxis constructs?..would I really give a shiet if Dan diluted a little stock to pay for further testing that could bring these treatments to market quicker?..heck NO...i'd be calling for him to dilute again and let's get some real data, real soon so we can proceed to market...I liken the analogy of a company that invents a new internal combustion motor that runs on water and does so economically...should they sell that patent or company to the high bidder or should they seek financing to brink this product to market themselves?..I think you can see that either a larger auto mfr. or an oil company would buy the patent and bury it...THINK about who makes huge money from CHEMO and DRUGS and RADIATION therapy and HOSPITALIZATION TIME???
THINK!!..These are big, RICH sources of power and capital. If Advaxis therapy's even so much as BEGIN to interupt the balance of money/power in this cancer treatment field, those powers will seek to squash the science by two methods: 1. outright purchase and stifling of the science and 2. use of said money/power to bring the powers of government(FDA) to limit and delay, if not outright, kill, any new therapys....
Now, I may be off my rocker here...but IF, BIG IF, this therapy has the power to do what we think it may be able to do...then Dan knows this, and it may explain why he has already brought on a mfg. guy from Merck.
The plan may be to become a full fledged mfrg company and bring the science directly to the people..to do this will take several more dilutions. ..only time will tell.
Man you guys are running SCARED!!!! What makes your delusional mind think they're not doing good? Is it your first post ever when you said "everyone don't freak out they dropped the seafood business"?
Well that is a VERY WRONG statement the "Company Background" for TD America, Scottrade just to name a couple was updated about a month ago and guess what? The seafood import business is STILL LISTED for the Company Background in the Quotes and Research section!!! Nice try with that reach though!! LOL!
Sentiment: Strong Buy
"I especially liked the medical part of it."
Sweet, so did I. I think that the one critical review that I read about HoloLens having a "limited field of view" won't matter initially for many educational and industrial applications, and therefore IMO that reviewer falls short due to his own "limited field of view".
I can't wait to know the pricing and availability.
...................HONOR, WHAT SAY YOU...?
Sentiment: Strong Buy
SWKS management knows what it is doing and is following its objectives the way it wants to do. It is easy for anyone to second guess what someone else who is responsibile for decision making should do. Whatever reason they have for holding cash makes sense to management. Sit back, relax and enjoy the ride, whichever direction it takes you. And do that as long as you believe they know what they are doing is best in the long run.
Paul, While I did not enjoy your bragging about your trades you made with your flip flopping a few years ago I do appreciate your input on the board. I respect you intelligence and knowledge of the subject matter. I just hope you are not playing people and are really excited about a great future for MVIS. I am invested and I want the company to be a big success. GL to you, Chuck
I know I know.... I think the point is proven. Complete inability to add to a discussion or answer a question.
Think WLO this year.
Wu's comments regarding the uptick in customer funded NRE (and cap-ex) coupled with the timing of it point towards inclusion in new devices in the latter half of the year. As always, with HIMX, you have to play connect the dots. The above are dots.